IDH1 (and IDH2) were the most predictive for long‐term survival, once again supporting the idea of considering IDHmt grade IV glioma as a distinct category in the 2021 WHO classification of central nervous system (CNS) tumors.14 Here, IDH2 is linked to central nervous system cancer.